Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 4.30M P/E - EPS this Y 94.10% Ern Qtrly Grth -
Income -26.16M Forward P/E -0.58 EPS next Y 88.30% 50D Avg Chg -22.00%
Sales 9.81M PEG - EPS past 5Y - 200D Avg Chg -73.00%
Dividend N/A Price/Book 0.50 EPS next 5Y - 52W High Chg -96.00%
Recommedations 2.00 Quick Ratio 0.81 Shares Outstanding 23.46M 52W Low Chg 11.00%
Insider Own 11.16% ROA -61.93% Shares Float 11.66M Beta 1.18
Inst Own 1.97% ROE -217.75% Shares Shorted/Prior 428.69K/830.82K Price 1.46
Gross Margin 54.11% Profit Margin -266.76% Avg. Volume 165,370 Target Price 1.00
Oper. Margin -143.99% Earnings Date Apr 15 Volume 63,032 Change 2.82%
About ReShape Lifesciences, Inc.

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

ReShape Lifesciences, Inc. News
03/28/24 ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
03/04/24 ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
02/22/24 ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
01/24/24 ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
12/20/23 ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
12/12/23 ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
11/21/23 ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds
11/08/23 ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan
11/06/23 ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update
11:30 AM ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
09/22/23 ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI
09/21/23 ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System
09/19/23 ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System
09/14/23 ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Device
08/07/23 ReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Update
08/03/23 ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate Update
07:31 AM ReShape Lifesciences® Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Software
06/28/23 ReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual Meeting
06/26/23 ReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0
06/23/23 Life Science Investor Forum: Presentations Now Available for Online Viewing
RSLS Chatroom

User Image Aquablue Posted - 17 hours ago

$RSLS Enough of this f’n bs. Let’s rock, you mgmt. weaklings.

User Image jr103 Posted - 17 hours ago

$RSLS

User Image BigPennyStockAlerts Posted - 17 hours ago

$RSLS - $0.19 ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System Free 10 day trial https://buy.stripe.com/eVa7vj8I68uI1CE9AD

User Image Stock_Titan Posted - 17 hours ago

$RSLS ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System https://www.stocktitan.net/news/RSLS/re-shape-lifesciences-r-receives-notice-of-allowance-for-additional-1ofwh2mt24nf.html

User Image Realtype101 Posted - 1 day ago

$RSLS Lets go 🥊

User Image Ben6288 Posted - 2 days ago

$RSLS someone just slapped for like 100k shares

User Image Greba1971 Posted - 3 days ago

$RSLS junk

User Image Ben6288 Posted - 3 days ago

$RSLS also the Cost to Borrow is now over 50%

User Image Ben6288 Posted - 3 days ago

$RSLS this is definitely getting accumulated, my guess is some news comes out soon.

User Image Phlipplein Posted - 3 days ago

$RSLS lets goo

User Image BuckeyeLucas Posted - 4 days ago

$RSLS hope this actually moves

User Image Torontoasian Posted - 5 days ago

$RSLS

User Image TrickofdaTrade Posted - 1 week ago

$RSLS No split ratio or date yet. Someone tag me when it drops please or tag the meeting.

User Image Ben6288 Posted - 1 week ago

$RSLS some big buys just came rolling in

User Image RollingDollar Posted - 1 week ago

$RSLS

User Image keepingthefaith1 Posted - 1 week ago

$RSLS 👀 ER

User Image BuckeyeLucas Posted - 1 week ago

$RSLS

User Image Ben6288 Posted - 1 week ago

$RSLS for a stock with a market cap of $4mil this has a lot of watchers

User Image Donlol Posted - 1 week ago

$RSLS this is done really don't see it coming back at all they can cut all cost they want no interest in this type of surgery

User Image Aroosana1 Posted - 1 week ago

$BRSH $nby $VTAK $rsls yallaa habibi!!!!

User Image StockBraker Posted - 2 weeks ago

$RSLS Lunch plans today?

User Image CubanBounty Posted - 2 weeks ago

$RSLS Setting up nicely

User Image stockboy66 Posted - 2 weeks ago

$RSLS Woman sues Ozempic makers over claims they knew it can cause problems https://www.dailymail.co.uk/news/article-13190703/Woman-suing-Ozempic-Novo-Nordisk-gastro-problems.html?ito=native_share_article-nativemenubutton

User Image Listentame Posted - 2 weeks ago

$RSLS This stock is done in a big way. Just look at the chart. Weight loss drugs better then placing device on stomach and regulating flow. Not worth the risk of surgery compared to just taking an IV and that will be a pill shortly.

User Image TheCooperVerse Posted - 2 weeks ago

$RSLS added 🤞🏼 $CLRO $RIVN $BTIF

User Image fattyblimp Posted - 2 weeks ago

$RSLS are these bumps up just plays for the bigger players to get out or is this a potential big gap up?

User Image Stockverified Posted - 2 weeks ago

$RSLS low float, can jump to $1+ anytime now

User Image RollingDollar Posted - 2 weeks ago

$RSLS

User Image Benzinga Posted - 2 weeks ago

The Least Invasive Surgical Option For Obesity On The Market? $RSLS https://www.benzinga.com/partner/health-care/24/03/37593601/the-least-invasive-surgical-option-for-obesity-on-the-market

User Image Donlol Posted - 2 weeks ago

$RSLS big news coming

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
STANKOVICH THOMAS Chief Financial Offi.. Chief Financial Officer Nov 04 Sell 0.27 8,393 2,266 332,761 11/10/22
STANKOVICH THOMAS Chief Financial Offi.. Chief Financial Officer Aug 05 Sell 0.47 4,728 2,222 351,791 08/11/22
Bandy Barton P. President and CEO President and CEO Aug 05 Sell 0.47 11,674 5,487 773,098 08/11/22
Bandy Barton P. President and CEO President and CEO Jun 01 Sell 0.96 11,309 10,857 796,214 06/06/22
STANKOVICH THOMAS Chief Financial Offi.. Chief Financial Officer May 31 Buy 0.91 20,000 18,200 365,627 06/01/22
STANKOVICH THOMAS Chief Financial Offi.. Chief Financial Officer Apr 01 Sell 1.13 5,038 5,693 350,156 04/08/22
Bandy Barton P. President and CEO President and CEO Jan 04 Sell 1.79 7,150 12,798 844,865 01/28/22
STANKOVICH THOMAS Chief Financial Offi.. Chief Financial Officer Jan 04 Sell 1.78 3,171 5,644 362,536 01/28/22